AMELUZ

AMINOLEVULINIC ACID HYDROCHLORIDE · Biofrontera Inc.

Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for AMELUZ, covering 2016-05-10 to 2026-06-03. Get the full timeline:

Most recent: EMA Authorised: Ameluz (5-aminolevulinic acid hydrochloride) — Biofrontera Bioscience GmbH